90 related articles for article (PubMed ID: 30628637)
1. MicroRNA-320a acts as a tumor suppressor in endometrial carcinoma by targeting IGF-1R.
Shu S; Liu X; Xu M; Gao X; Chen S; Zhang L; Li R
Int J Mol Med; 2019 Mar; 43(3):1505-1512. PubMed ID: 30628637
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-381 inhibits cell proliferation and invasion in endometrial carcinoma by targeting the IGF-1R.
Tu C; Wang F; Wan J
Mol Med Rep; 2018 Mar; 17(3):4090-4098. PubMed ID: 29257334
[TBL] [Abstract][Full Text] [Related]
3. eIF4E‑related miR‑320a and miR‑340‑5p inhibit endometrial carcinoma cell metastatic capability by preventing TGF‑β1‑induced epithelial‑mesenchymal transition.
Zhang HH; Li R; Li YJ; Yu XX; Sun QN; Li AY; Kong Y
Oncol Rep; 2020 Feb; 43(2):447-460. PubMed ID: 31894279
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑320a inhibition decreases insulin‑induced KGN cell proliferation and apoptosis by targeting PCGF1.
Yang L; Li Y; Wang X; Liu Y; Yang L
Mol Med Rep; 2017 Oct; 16(4):5706-5712. PubMed ID: 28849208
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA‑539 inhibits the proliferation and invasion of bladder cancer cells by regulating IGF‑1R.
Liao G; Chen F; Zhong J; Jiang X
Mol Med Rep; 2018 Apr; 17(4):4917-4924. PubMed ID: 29393438
[TBL] [Abstract][Full Text] [Related]
6. Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer.
Okato A; Goto Y; Kurozumi A; Kato M; Kojima S; Matsushita R; Yonemori M; Miyamoto K; Ichikawa T; Seki N
Int J Oncol; 2016 Jul; 49(1):111-22. PubMed ID: 27212625
[TBL] [Abstract][Full Text] [Related]
7. miR-320a modulates cell growth and chemosensitivity via regulating ADAM10 in gastric cancer.
Ge X; Cui H; Zhou Y; Yin D; Feng Y; Xin Q; Xu X; Liu W; Liu S; Zhang Q
Mol Med Rep; 2017 Dec; 16(6):9664-9670. PubMed ID: 29152656
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation of miR-320a by ATF2, ELK1 and YY1 induces cancer cell apoptosis under ionizing radiation conditions.
Hu Z; Tie Y; Lv G; Zhu J; Fu H; Zheng X
Int J Oncol; 2018 Oct; 53(4):1691-1702. PubMed ID: 30066913
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R.
Zhang Y; Chen X; Lian H; Liu J; Zhou B; Han S; Peng B; Yin J; Liu W; He X
Oncol Rep; 2014 Mar; 31(3):1445-52. PubMed ID: 24378652
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑320a suppresses tumour cell proliferation and invasion of renal cancer cells by targeting FoxM1.
Zhao S; Wang Y; Lou Y; Wang Y; Sun J; Luo M; Li W; Miao L
Oncol Rep; 2018 Oct; 40(4):1917-1926. PubMed ID: 30066895
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑186 targets IGF‑1R and exerts tumor‑suppressing functions in glioma.
Jiang J; Wang W; Fang D; Jin X; Ding L; Sun X
Mol Med Rep; 2017 Nov; 16(5):7821-7828. PubMed ID: 28944896
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
Gong Y; Ren J; Liu K; Tang LM
World J Gastroenterol; 2015 Mar; 21(10):2949-58. PubMed ID: 25780292
[TBL] [Abstract][Full Text] [Related]
14. Increased insulin-like growth factor 1 receptor (IGF1R) expression in small cell lung cancer and the effect of inhibition of IGF1R expression by RNAi on growth of human small cell lung cancer NCI-H446 cell.
Wang Z; Lu P; Liang Z; Zhang Z; Shi W; Cai X; Chen C
Growth Factors; 2015; 33(5-6):337-46. PubMed ID: 26430715
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑455 is downregulated in gastric cancer and inhibits cell proliferation, migration and invasion via targeting insulin‑like growth factor 1 receptor.
Zhang S; Yin WL; Zhang X; Zhang XY
Mol Med Rep; 2017 Sep; 16(3):3664-3672. PubMed ID: 28714005
[TBL] [Abstract][Full Text] [Related]
16. The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.
Sun KX; Chen Y; Chen S; Liu BL; Feng MX; Zong ZH; Zhao Y
Oncotarget; 2016 Feb; 7(8):9236-49. PubMed ID: 26843615
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA tumor suppressor candidate 7 advances chemotherapy sensitivity of endometrial carcinoma through targeted silencing of miR-23b.
Shang C; Lang B; Ao CN; Meng L
Tumour Biol; 2017 Jun; 39(6):1010428317707883. PubMed ID: 28653877
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1.
Li L; Qu YW; Li YP
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2816-2822. PubMed ID: 28682437
[TBL] [Abstract][Full Text] [Related]
19. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
He Z; Xu H; Meng Y; Kuang Y
Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
[TBL] [Abstract][Full Text] [Related]
20. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
